Approval · Notice of Compliance 9684 · 2008
PRO-GABAPENTIN: Notice of Compliance 9684
Issued July 17, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9684
- Date
- July 17, 2008
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antiepileptic agent
- Canadian reference product
- NEURONTIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-GABAPENTIN | 02310473 | Marketed |
| PRO-GABAPENTIN | 02310481 | Marketed |
| PRO-GABAPENTIN | 02310449 | Marketed |
| PRO-GABAPENTIN | 02310457 | Marketed |
| PRO-GABAPENTIN | 02310465 | Marketed |
Medicinal ingredients
- GABAPENTIN 600 MG per TAB
- GABAPENTIN 800 MG per TAB
- GABAPENTIN 100 MG per CAP
- GABAPENTIN 300 MG per CAP
- GABAPENTIN 400 MG per CAP